Michael Salgaller is named as a lobbyist on federal disclosure filings for 4 clients through The Conafay Group, LLC and 1 other registrant. The most recent filing naming them posted in July 2015. Issues reported include Medical/Disease Research/Clinical Labs, Science/Technology and Health Issues.
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| WOODBERRY & ASSOCIATES ON BEHALF OF COLORADO STATE UNIVERSITY FOUNDATION | THE CONAFAY GROUP, LLC | Q2 2015 | Science/Technology, Medical/Disease Research/Clinical Labs, Health Issues |
| COLORADO STATE UNIVERSITY | THE CONAFAY GROUP, LLC | Q3 2013 | Medical/Disease Research/Clinical Labs, Health Issues |
| CARY PHARMACEUTICALS | THE CONAFAY GROUP, LLC | Q4 2012 | Budget/Appropriations, Science/Technology, Medical/Disease Research/Clinical Labs |
| FABIANI & COMPANY ON BEHALF OF AURA | MICHAEL SALGALLER | Q3 2012 | Medical/Disease Research/Clinical Labs, Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2015 | 1 | 1 |
| 2014 | 1 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Michael Salgaller. See the Capitol Clarity rankings and method.